At Children's Vascular Anomalies Center, our largest patient population continues to consist of children with hemangiomas. The most exciting development is the recent discovery of the effectiveness of oral Propranolol in the management of infantile hemangioma. This treatment has revolutionized the care of children with hemangiomas. Since October 2009, Children's has treated 90 children with oral Propranolol and our experts have reported this experience at the annual meeting of the American Society of Pediatric Hematology/Oncology.

Other innovations and advancements include:

  • Our experience in managing PHACES syndrome and our involvement with the international PHACES registry.
  • Our experience in managing lymphangiomatosis, use of interferon treatment and with novel treatments such as the medication Rapamycin.
  • Our experienced Interventional Radiology and Vascular Surgery staff that provides embolization and sclerotherapy procedures with novel agents such as Bleomycin for the management of complicated vascular malformations.
  • Our otolaryngologists and plastic surgeons have expertise in using multi-modal laser therapies to treat vascular anomalies.